CA2237138A1 - 25-hydroxyvitamin d3-1.alpha.-hydroxylase and dna encoding the hydroxylase - Google Patents

25-hydroxyvitamin d3-1.alpha.-hydroxylase and dna encoding the hydroxylase Download PDF

Info

Publication number
CA2237138A1
CA2237138A1 CA002237138A CA2237138A CA2237138A1 CA 2237138 A1 CA2237138 A1 CA 2237138A1 CA 002237138 A CA002237138 A CA 002237138A CA 2237138 A CA2237138 A CA 2237138A CA 2237138 A1 CA2237138 A1 CA 2237138A1
Authority
CA
Canada
Prior art keywords
leu
arg
ala
val
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002237138A
Other languages
English (en)
French (fr)
Inventor
Hideharu Anazawa
Hiroko Shimada
Seiji Sugimoto
Tatsuo Suda
Toshimasa Shinki
Takao Saruta
Yuzuru Ishimura
Matsuhiko Hayashi
Shu Wakino
Toshiaki Monkawa
Tadashi Yoshida
Hiromichi Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of CA2237138A1 publication Critical patent/CA2237138A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002237138A 1997-07-10 1998-07-09 25-hydroxyvitamin d3-1.alpha.-hydroxylase and dna encoding the hydroxylase Abandoned CA2237138A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP18539997 1997-07-10
JP185399/97 1997-07-10
JP9322651A JPH1175863A (ja) 1997-07-10 1997-11-25 ２５−ヒドロキシビタミンＤ３−１α−水酸化酵素および該酵素をコードするＤＮＡ
JP322651/97 1997-11-25

Publications (1)

Publication Number Publication Date
CA2237138A1 true CA2237138A1 (en) 1999-01-10

Family

ID=26503073

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002237138A Abandoned CA2237138A1 (en) 1997-07-10 1998-07-09 25-hydroxyvitamin d3-1.alpha.-hydroxylase and dna encoding the hydroxylase

Country Status (4)

Country Link
US (2) US6274359B1 (cg-RX-API-DMAC7.html)
EP (2) EP0890643A3 (cg-RX-API-DMAC7.html)
JP (1) JPH1175863A (cg-RX-API-DMAC7.html)
CA (1) CA2237138A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1024193A4 (en) * 1997-07-22 2004-12-15 Chugai Pharmaceutical Co Ltd METHOD FOR SCREENING GENES USING CELL CORE RECEPTORS.
US6096876A (en) * 1997-08-06 2000-08-01 Shriners Hospitals For Children 1-α-hydroxylase materials and methods
DE60021720T2 (de) 1999-05-04 2006-06-01 Strakan International Ltd. Androgen glykoside und die androgenische aktivität davon
US20030062225A1 (en) * 2001-10-03 2003-04-03 Stucky Paul A. Elevator load bearing assembly having a detectable element that is indicative of local strain
US7416899B2 (en) * 2002-07-29 2008-08-26 Tohoku Techno Arch Co., Ltd. Method and apparatus for measuring trace ingredients in water
ES2904546T3 (es) 2006-02-03 2022-04-05 Opko Renal Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
SI2037936T1 (sl) 2006-06-21 2014-11-28 Opko Renal, Llc Postopek zdravljenja in prepreäśevanja sekundarnega hiperparatiroidizma
CA2683628C (en) 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
PT2148661E (pt) 2007-04-25 2013-03-06 Proventiv Therapeutics Llc Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
FI3225243T3 (fi) 2007-04-25 2025-10-13 Opko Renal Llc Menetelmä sekundaarisen hyperparatyreoosin turvalliseen ja tehokkaaseen hoitoon ja ehkäisyyn kroonisen munuaistaudin yhteydessä
US8962239B2 (en) 2008-04-02 2015-02-24 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
US8647616B2 (en) 2012-02-14 2014-02-11 Loma Linda University Agents and method for treating inflammation-related conditions and diseases
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
WO2016130845A1 (en) 2015-02-11 2016-08-18 Loma Linda University A method for utilizing engineered dendritic cells to induce gut-homing regulatory t cells and treat gut inflammation
UA129792C2 (uk) 2016-03-28 2025-08-06 Ейрджен Фарма Лтд. Способи лікування вітаміном d
WO2017214190A1 (en) * 2016-06-06 2017-12-14 Loma Linda University Engineered dendritic cells that express 1a-hydroxylase and uses thereof for treating immune-mediated diseases
CN107365805B (zh) * 2017-05-12 2021-08-03 太原市威尔潞威科技发展有限公司 骨化二醇发酵的补料培养基、发酵的补料方法及其发酵方法
CN114075556B (zh) * 2021-11-18 2023-08-04 江南大学 可羟基化维生素d3 c-1和c-25的p450酶及其基因、表达载体、重组菌与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554106A (en) 1984-11-01 1985-11-19 Wisconsin Alumni Research Foundation Method for preparing 1α-hydroxyvitamin D compounds
JP3024154B2 (ja) * 1990-02-06 2000-03-21 住友化学工業株式会社 チトクロムＰ４５０ｃ▲下２▼▲下５▼遺伝子
EP0477961B1 (en) 1990-09-26 1996-09-11 Sumitomo Chemical Company, Limited Mitochondrial P450
US5786191A (en) * 1992-04-09 1998-07-28 Goldstein; Joyce A. Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450 2C subfamily
US5981176A (en) * 1992-06-17 1999-11-09 City Of Hope Method of detecting and discriminating between nucleic acid sequences
US5593833A (en) * 1992-07-31 1997-01-14 Garvan Institute Of Medical Research Assessment of allelic variation in vitamin D receptor correlated to bone density or turnover
EP1024193A4 (en) 1997-07-22 2004-12-15 Chugai Pharmaceutical Co Ltd METHOD FOR SCREENING GENES USING CELL CORE RECEPTORS.
US6096876A (en) 1997-08-06 2000-08-01 Shriners Hospitals For Children 1-α-hydroxylase materials and methods
CN1301298A (zh) 1998-03-25 2001-06-27 卡坦诺根公司 用于预防和治疗癌症的方法

Also Published As

Publication number Publication date
US20020031798A1 (en) 2002-03-14
EP1074627A3 (en) 2001-04-04
US6274359B1 (en) 2001-08-14
JPH1175863A (ja) 1999-03-23
EP0890643A2 (en) 1999-01-13
EP0890643A3 (en) 1999-04-28
EP1074627A2 (en) 2001-02-07

Similar Documents

Publication Publication Date Title
US6274359B1 (en) 25-hydroxyvitamin D3-1α-hydroxylase and DNA encoding the hydroxylase
US6962984B2 (en) IgA nephropathy-related DNA
EP0915156A1 (en) IgA NEPHROPATHY-ASSOCIATED GENE
JP4880116B2 (ja) 劇症ｃ型肝炎ウイルス株の遺伝子
EP1197556A1 (en) Useful polypeptide
JPWO2001000848A1 (ja) 有用ポリペプチド
US6025480A (en) Isolated nucleic acid molecules encoding P57KIP2
WO1999031239A1 (fr) PROTEINE Nap1 HUMAINE
US20080044425A1 (en) Polypeptides having phospholipase a2 activity
WO1999062956A1 (en) Angiopoietin related gene sequence scarface 3
WO2002015925A1 (fr) Technique de regulation de l'apoptose et polypeptide de regulation d'apoptose
JP2001521399A (ja) 哺乳類のグルクロニルｃ５−エピメラーゼをコードするｄｎａ配列およびその産生法
CA2329683C (en) Iga nephropathy-related dna
EP1180525B1 (en) Transcriptional activation inhibitory protein
US6790944B1 (en) DNA encoding IGA nephropathy indicating protein
JP2000189168A (ja) 新規転写伸長抑制因子
WO2001066716A1 (fr) Polypeptide ayant une activite de phosphodiesterase
WO2000031132A1 (fr) Nouveau polypeptide
WO2000063392A1 (en) Novel tyrosine phosphatase
JPWO1999063085A1 (ja) ＩｇＡ腎症関連ＤＮＡ
JPWO2002064769A1 (ja) 新規疾患マーカー
JPH11236398A (ja) 新規ポリペプチド
WO2000040609A1 (fr) Nouvelle proteine
EP1108725A1 (en) Novel polypeptide
JPWO1998039437A1 (ja) 新規アポトーシス関連ｄｎａ

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued